|
Symbol
|
LVBVLK | XRYLTQ | IHTEFG | LCDQLK | LTHCLK | OOJRCH | AAIDTQ | 1016BC | POMRCH | PRZRCH | PWCRCH | RMAA0V | RMBX0V | RMATBV | RMAZDV | LZMRCH | LZORCH | RMBJ7V | MAIRCH | RCDRCH |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Name | LUKB Autocallable Multi Reverse Convertible | Multi Reverse Convertible | Reverse Convertible | LUKB Multi Reverse Convertible | LUKB Softcallable Multi Reverse Convertible | Worst of Callable Reverse Convertible | Worst of Reverse Convertible | Reverse Convertible | Worst of Callable Reverse Convertible | Worst of Callable Reverse Convertible | Autocallable Reverse Convertible | Multi Vonti | Multi Vonti | Multi Vonti | Multi Vonti | Worst of Reverse Convertible | Worst of Callable Reverse Convertible | Multi Vonti | Worst of Callable Reverse Convertible | Autocallable Reverse Convertible |
|
Underlying
|
Nestlé S.A. / Swatch Group I / Swiss Life Hldg. N / Swiss RE AG | Compagnie Financière Richemont SA / Novartis Sandoz Basket / Roche PS / Swatch Group I / Swiss RE AG | Compagnie Financière Richemont SA / Lonza Group N / Sonova Hldg. AG / Swiss RE AG / Swisscom N | Partners Group Hldg. AG / Swiss Life Hldg. N / Swiss RE AG | ABB / Nestlé S.A. / Novartis AG / Roche PS / Swiss RE AG | Barry Callebaut AG / Nestlé S.A. / Roche PS / Swiss RE AG / UBS Group AG | Swiss Life / Swiss Re / Zurich | Nestlé S.A. / Sika AG / Swiss RE AG | Swiss Re / UBS / Zurich | Lonza Group N / Swiss Life Hldg. N / Swiss RE AG | Kühne & Nagel Intl. AG / Logitech International SA / Lonza Group N / Swiss RE AG / UBS Group AG | Swiss Life Hldg. N / Swiss RE AG / Zurich Insurance Group AG / Helvetia Baloise Holding AG | Schindler PS / Swiss RE AG / Swisscom N | Companie Financière Richemont SA / Geberit AG / Swiss RE AG | Nestlé S.A. / Partners Group Hldg. AG / Swiss RE AG | Holcim AG / Swiss RE AG / Lonza Group N | Swiss Life Hldg. N / Swiss RE AG / Helvetia Baloise Holding AG | Sika AG / Swiss RE AG / UBS Group AG / Zurich Insurance Group AG | Swiss Life / Swiss Re / Zurich | Novartis AG / Roche PS / Swiss Life Hldg. N / Swiss RE AG / Zurich Insurance Group AG |
|
Issuer
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Date of maturity
|
20.07.2026 | 22.09.2028 | 28.06.2029 | 03.06.2026 | 09.07.2027 | 15.07.2026 | 19.07.2027 | 06.11.2026 | 31.07.2026 | 24.02.2027 | 27.06.2029 | 26.04.2027 | 31.05.2027 | 25.06.2026 | 09.07.2026 | 31.07.2026 | 07.08.2029 | 19.08.2027 | 24.09.2027 | 26.09.2028 |
| Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Strike price
|
172.51 | 160.62 | 176.28 | 824.8414 | 58.7776 | 997.10 | 265.045 | 158.665 | 103.5375 | 416.78 | 364.13 | 113.44 | 103.04 | 407.30 | 791.945 | 110.6625 | 110.5875 | 142.30 | 103.9125 | 97.685 |
| Max. yield p.a. | 23.41% | 10.01% | - | 11.77% | 6.16% | 15.41% | 1.86% | 21.54% | 3.57% | 6.47% | 7.44% | 8.65% | 5.89% | 4.63% | 12.27% | 6.09% | 5.73% | 13.14% | 5.78% | 5.17% |
| Bid | - | 87.63 | 88.49 | - | - | 97.33 | 101.16 | 94.64 | 100.47 | 97.82 | 91.58 | 96.90 | 97.70 | 99.40 | 98.00 | 98.86 | 96.41 | 91.20 | 98.34 | 99.10 |
| Ask | - | 88.43 | - | - | - | 98.13 | 101.97 | 95.39 | 101.28 | 98.62 | 92.38 | 97.90 | 98.70 | 100.40 | 99.00 | 99.66 | 97.21 | 92.20 | 99.14 | 99.90 |